SEC Form 3/A · accession 0000816956-26-000063
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owner
Kimberly Lockwood
Officer — Interim Corp Controller & PAO
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 12:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,868 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options To Purchase Common StockF1 | $59.96 | holding | — | — | — | — | Mar 1, 2028 | Common Stock | 1,400 | — | D |
| Options To Purchase Common StockF2 | $78.76 | holding | — | — | — | — | Mar 1, 2029 | Common Stock | 3,200 | — | D |
| Options To Purchase Common StockF2 | $97.69 | holding | — | — | — | — | Mar 2, 2030 | Common Stock | 3,500 | — | D |
| Options To Purchase Common StockF2 | $122.55 | holding | — | — | — | — | Mar 1, 2031 | Common Stock | 3,500 | — | D |
| Options To Purchase Common StockF2 | $144.55 | holding | — | — | — | — | Mar 1, 2032 | Common Stock | 2,750 | — | D |
| Options To Purchase Common StockF2 | $96.16 | holding | — | — | — | — | Mar 1, 2033 | Common Stock | 2,500 | — | D |
| Options To Purchase Common StockF2 | $79.95 | holding | — | — | — | — | Mar 1, 2034 | Common Stock | 2,500 | — | D |
| Options To Purchase Common StockF2 | $58.33 | holding | — | — | — | — | Mar 3, 2035 | Common Stock | 4,500 | — | D |
| RSUs (Restricted Stock Units)F3 | $0.00 | holding | — | — | — | — | Mar 2, 2036 | Common Stock | 2,839 | — | D |
| RSUs (Restricted Stock Units)F3 | $0.00 | holding | — | — | — | — | May 11, 2036 | Common Stock | 2,838 | — | D |
Explanation of responses
- F1The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- F2The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- F3Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
Remarks
This Form 3/A is filed solely to correct the officer title which was incorrect in the initial filing.